What are Tumors with Genetic Mutations?

April 11, 2021 - All cancer is the result of gene mutations, which could be caused by the environment, exposure to chemicals, exposure to radiation, aging, hormones, or other factors in the body. Over time, multiple mutations can occur in a single cell, then it will divide and grow in a way that becomes a cancer. This can take years. More and more cancers have been found to be hereditary, meaning they are associated with specific gene mutations that are inherited within members of the same family. When a person is born with such a mutation, every cell in his or her body, including the eggs and sperm, which means it can be passed to the next generation. Those who inherit these genetic mutations have a higher risk of developing certain types of cancer.

April 08, 2021 - Ovarian cancer has been in the news much more over recent years, due to the number of women who have developed ovarian cancer after using talcum powder for feminine hygiene.  The primary type of ovarian tumors are epithelial tumors, accounting for 85-90 percent of all ovarian cancers. There are subtypes of epithelial tumors as well; epithelial ovarian cancer can spread to the lining and organs of the pelvis, or even to the lungs, liver, brain, bones, and skin. Below are the types of ovarian cancers along with their typical treatments and survival rates...

What is the DigniCap Scalp Cooling System? Since chemotherapy affects cells that are in division and growth, all body cells can be affected. Healthy cells with a high growth rate—like hair—are more likely to be adversely affected by chemotherapy drugs. Scalp cooling is a proven approach to reduce chemotherapy-induced hair loss; reducing the temperature to the scalp decreases the blood flow to the area, allowing less chemotherapy to reach the scalp...

How Johnson & Johnson Failed to Exclude Key Plaintiffs’ Experts - A Daubert claim was filed in which J & J asked that some of the experts on the Plaintiffs’ side should be disqualified as experts, therefore unable to testify. The judge in the case did not exclude these experts. The goal in this—and any other—Daubert Hearing is to evaluate whether the expert witnesses and their evidence are credible. If Johnson & Johnson had prevailed at this particular Daubert Hearing, almost 12,000 talcum powder ovarian cancer lawsuits could have been dismissed—79 percent of the total of all the outstanding baby powder ovarian cancer lawsuits.

The long-awaited Daubert decision was given by Chief Judge Wolfson, the judge overseeing the Johnson & Johnson baby powder ovarian cancer multidistrict litigation at the end of April 2020. Wolfson gave a 141-page opinion that comprehensively analyzed the factors which will determine whether scientific expert witnesses (both for the plaintiffs and for the defendants) will be allowed to testify on various issues that are critical to the cases pending on baby powder ovarian cancer...